Search for content, post, videos

Potential merger between AstraZeneca and Gilead

Pascal Soriot
AstraZeneca has made a preliminary approach to Gilead Sciences about a potential merger, according to Bloomberg. AstraZeneca informally contacted Gilead last month to gauge its interest in a possible tie-up asking not to be identified because the details are private, reports Bloomberg. AstraZenec
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.